Abstract:Background: Developmental disorders result from impaired prenatal development, often attributed to deleterious genetic variations. Knockout mouse models are critical tools in diseases research, but null mutations of orthologous genes in humans and mice often resulted in different phenotypes. As phenotypes are described during developmental processes, we explored the temporal patterns of gene expression trajectories during development. Methods: We utilized Spearman correlation analysis to compute the expression similarity of orthologous genes in temporal expression data of humans and mice. Gene list associated with developmental disorders was downloaded from the Developmental Disorders Genotype -to -Phenotype (DDG2P) database and classified according to the full spectrum of intolerance to loss -of -function (FUSIL) categorization. The phenotypic similarities of orthologous genes were quantified using Phenodigm scores derived from the calculations based on Human Phenotype Ontology (HPO) and Model Phenotype Ontology (MPO) terms. The phenotypic similarities of ionotropic glutamate receptors (iGluRs) genes with protein -truncating variants (PTVs) were computed as refined Phenodigm scores, utilizing manually curated profiles from the HPO terms and MPO terms. Results: This study investigated the expression trajectories of DDG2P genes and their association with phenotypic similarities between humans and mice. We observed that DDG2P genes showed more similar expression trajectories in major tissues compared to non-DDG2P genes. Additionally, in DDG2P genes, viable with phenotype (VP) genes with similar expression trajectories in the brain exhibited analogous phenotypes across humans and mice (autosomal dominant genes: Wilcoxon test: Z =11, P=0.02; autosomal recessive genes: Wilcoxon test: Z =9, P=0.003). To illustrate the feasibility of utilizing gene expression trajectory similarity to assist in inferring phenotypic similarity, we examined a gene family associated with neurodevelopmental disorder. Our findings suggest that similar expression trajectories of iGluRs genes in the brain and cerebellum could assist in predicting comparable neurological phenotypes across species. Conclusions: The gene expression trajectory offered a potential elucidation for the disparate phenotypes observed due to null mutations in humans and mice. Leveraging gene expression trajectories might enhance the precision in predicting candidate pathogenic genes.

Developmental disorders caused by haploinsufficiency of transcriptional regulators: a perspective based on cell fate determination

Evolution and dysfunction of human cognitive and social traits: a transcriptional regulation perspective

Transcription Factors That Govern Development and Disease: An Achilles Heel in Cancer

Transcription Factors Dysregulated in Three Complex Birth Defects Datasets

Disorders of Transcriptional Regulation: An Emerging Category of Multiple Malformation Syndromes

Divergent phenotypes in constitutive versus conditional mutant mouse models of Sifrim-Hitz-Weiss syndrome

Implications of Dosage Deficiencies in CTCF and Cohesin on Genome Organization, Gene Expression, and Human Neurodevelopment

ZMYND11 Functions in Bimodal Regulation of Latent Genes and Brain-like Splicing to Safeguard Corticogenesis

Chromodomain Helicase DNA-Binding Proteins in Stem Cells and Human Developmental Diseases

Rethinking gene regulatory networks in light of alternative splicing, intrinsically disordered protein domains, and post-translational modifications

Transcription factor binding site affinity and the link to phenotype

How do stochastic processes and genetic threshold effects explain incomplete penetrance and inform causal disease mechanisms?

Regulation of human development by ubiquitin chain editing of chromatin remodelers

Chromatin Remodelling Complex Dosage Modulates Transcription Factor Function in Heart Development

Gain and loss of function variants in EZH1 disrupt neurogenesis and cause dominant and recessive neurodevelopmental disorders

The Role of Bcl11 Transcription Factors in Neurodevelopmental Disorders

In vivo response to high-resolution variation of Tbx1 mRNA dosage.

aiHumanoid Simulations Uncover Dominant-Negative Effects in HNRNPH2-Related Neurodevelopmental Disorders

Combinatorial Limits of Transcription Factors and Gene Regulatory Networks in Development and Evolution

DLG2 knockout reveals neurogenic transcriptional programs underlying neuropsychiatric disorders and cognition

Gene Expression Trajectories Aiding the Unveiling of Phenotypic Similarities in Developmental Disorders: Insights from Human-Mouse Comparative Analysis